Skinvisible Inc (SKVI) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access SKVI quarterly Cash Flow →
A period-by-period view of cash flow from Skinvisible Inc to Dec 31 2021 helps clarify how Dec 31 2025's cash position has changed over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-1.06
Depreciation & amortization0.02
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Other Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Debt Conversion Converted Instrument Shares Issued-
Gain Loss On Conversion Of Debt-
Accured Expenses Converted To Notes-
Increase Decrease In Prepaid Royalty Fees-
Debt Instrument Increase Accrued Interest0.57
Debt Paid With Common Stock-
Loss On Conversion Of Debt-
Accrued Expenses Converted To Notes-
Increase Decrease Gains On Extinguishment Of Debt-
Common Stock Payable For Debt-
Stock Issued During Period Value Conversion Of Interest-
Stock Issued During Period Value Issued For Services-
Extinguishment Of Debt Gain Loss Net Of Tax-
Income taxes0.00
Unrealized Gain (Loss) on Derivatives0.00
Increase (Decrease) in Due from Related Parties0.03
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.39
Increase (Decrease) in Other Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.01
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-0.04
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Indefinite Lived Intangible Assets Acquired During Period-
Stock Issued During Period Value Other-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.01
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.02
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments On Related Parties Convertible Notes Payable-
Advances To Related Parties-
Repayments Of Convertible Notes Payable-
Proceeds From Investment In Subsidiary-
Proceeds From Investment Subsidiary-
Cash Beginning Of Period-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.03
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.04
Total Cash Flow-0.01
4 historic quarters locked

Sign in to unlock the full Skinvisible Inc cash flow history.

About Skinvisible Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001663577-26-000087

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License